180 related articles for article (PubMed ID: 3551883)
1. Mode of hypocholesterolemic action of probucol in animals and man.
Beynen AC
Artery; 1987; 14(2):113-26. PubMed ID: 3551883
[TBL] [Abstract][Full Text] [Related]
2. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein fractions and receptors: a role for probucol?
Bilheimer DW
Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051
[TBL] [Abstract][Full Text] [Related]
5. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
Hong SC; Zhao SP; Wu ZH
Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
[TBL] [Abstract][Full Text] [Related]
6. Effects of probucol on lipoprotein protein kinetics.
Nestel PJ
Artery; 1982; 10(2):95-8. PubMed ID: 7092582
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe and mild hypercholesterolaemia with probucol and neomycin.
Miettinen TA; Toivonen I
Postgrad Med J; 1975; 51(8):suppl 71-5. PubMed ID: 215985
[TBL] [Abstract][Full Text] [Related]
8. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
9. [The effect of probucol and its new analog on cholesterol and lipoprotein metabolism in rabbit cultured hepatocytes].
Mambetisaeva ET; Kosenkov EI; Podrez EA; Samuilov IaD; Kosykh VA
Biokhimiia; 1994 Jan; 59(1):118-25. PubMed ID: 8117833
[TBL] [Abstract][Full Text] [Related]
10. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G
Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
[TBL] [Abstract][Full Text] [Related]
11. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
Schonfeld G; Witztum J; Basich P
Artery; 1982; 10(2):99-104. PubMed ID: 7092583
[TBL] [Abstract][Full Text] [Related]
12. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
Artery; 1982; 10(2):88-94. PubMed ID: 7092581
[TBL] [Abstract][Full Text] [Related]
13. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
Gylling H; Miettinen TA
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
[TBL] [Abstract][Full Text] [Related]
14. Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice.
Tomikawa M; Nakayasu T; Tawara K; Abiko Y
Atherosclerosis; 1981 Oct; 40(2):101-13. PubMed ID: 6946776
[TBL] [Abstract][Full Text] [Related]
15. [Probucol: mechanism of action (author's transl)].
Infante R
Nouv Presse Med; 1980 Oct; 9(40):2976-80. PubMed ID: 7443434
[TBL] [Abstract][Full Text] [Related]
16. Primate model for the study of hepatic metabolism of lipoprotein cholesterol.
Redinger RN; Morello A; La Morte WW
J Lab Clin Med; 1986 Feb; 107(2):103-11. PubMed ID: 3456004
[TBL] [Abstract][Full Text] [Related]
17. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI
Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
[TBL] [Abstract][Full Text] [Related]
18. Plasma lipoproteins are required for both basal and stress-induced adrenal glucocorticoid synthesis and protection against endotoxemia in mice.
Hoekstra M; Korporaal SJ; Li Z; Zhao Y; Van Eck M; Van Berkel TJ
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1038-43. PubMed ID: 20858753
[TBL] [Abstract][Full Text] [Related]
19. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
20. The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins.
Atmeh RF; Stewart JM; Boag DE; Packard CJ; Lorimer AR; Shepherd J
J Lipid Res; 1983 May; 24(5):588-95. PubMed ID: 6875383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]